Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 3rd Pacer--DECLARATION OF MAC LECKRON IN SUPPORT OF TECHNOLOGY

"3. Currently, Alliacense is in discussion with companies in various industries
regarding participation in the MMP Portfolio licensing program, in which prospective licensees
compete within their industry segment for “tiered” pricing, which rewards early movers with
lower royalty rates. Because of this competitive environment, Alliacense conducts all of its
negotiations confidentially to prevent information that is competitively sensitive to Alliacense and TPL from being disseminated to other prospective licensees or third parties. Negotiations are conducted between Alliacense and the prospective licensee, and despite frequent requests,
exclude third parties such as components vendors and other third parties."

I guess it still sounds nice to Mac; too bad it rings mighty hollow.

Share
New Message
Please login to post a reply